FDA delays Capricor’s deramiocel PDUFA date to review new datanews2026-08-24T15:10:23+00:00August 24th, 2026|Endpoints News|
TwinStrand wins patent case; GSK’s hepatitis B drug approved in Japannews2026-08-24T15:06:08+00:00August 24th, 2026|Endpoints News|
News on AstraZeneca, Cytokinetics, Novartis — what to look out for at ESC 2026news2026-08-24T14:55:57+00:00August 24th, 2026|Endpoints News|
Roche bets up to $2.3B on Hanmi’s early-stage muscle-building obesity assetnews2026-08-24T10:56:51+00:00August 24th, 2026|Endpoints News|
Option-to-acquire deals remain rare in biotech’s buzzy M&A seasonnews2026-08-24T10:30:05+00:00August 24th, 2026|Endpoints News|
Third death in China’s expedited trials; Merck and Moderna’s cancer vaccine win; and morenews2026-08-22T10:00:07+00:00August 22nd, 2026|Endpoints News|
RFK Jr. takes another step toward dismantling vaccine recommendationsnews2026-08-21T16:50:51+00:00August 21st, 2026|Endpoints News|
Chronic pain biotech co-founded by Vivek Ramaswamy joins reverse merger trainnews2026-08-21T15:24:23+00:00August 21st, 2026|Endpoints News|
Genentech invests $750M in new factory; Bavarian Nordic delays Lyme trialnews2026-08-21T14:52:26+00:00August 21st, 2026|Endpoints News|
As Trump 2.0 targets federal research, a new study shows the stakesnews2026-08-21T13:00:16+00:00August 21st, 2026|Endpoints News|
